I am the Chief Corporate Development Officer at Danimer Scientific, a biotechnology company that produces polyhydroxyalkanoate. PHA is a sustainable renewable biopolymer that enables the creation of biodegradable and compostable products which are a great alternative to traditional plastics. As a business and R&D leader specializing in external collaboration and open innovation, I have numerous years of global experience enhancing development pipelines and increasing revenues through creative deal-making. I have a proven track record of building innovative alliances and am skilled in structuring, negotiating and implementing complex collaborations that expand capabilities to deploy new global products and technologies.With cross-functional experience in a broad base of product categories, across numerous industries, including food and beverage, health and wellness, sustainability and pharmaceuticals, I am well-suited to lead corporate development, act in an advisory role or as a board member. I have a strong reputation for being driven, pragmatic, trustworthy and collaborative. I am interested in expanding a company's business by building collaborations that are forward-thinking, drive revenues, enhance shareholder value and positively impact our world. Specialties:#Corporate strategy development and implementation#Delivering innovative solutions via cross-functional collaboration#Enabling new category development via strategic alliances#Executing growth strategies through product and technology scouting, due diligence, co-development, licensing, mergers and acquisitions, integration and out-licensing / divestitures#Prescription drugs, consumer goods, cosmetics, infant nutrition, personalized nutrition, food and beverages, sustainable packaging and agtech/regeneration